Early research (Phase 1)Study completedNCT03186989
What this trial is testing
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease
Who this might be right for
Mild Alzheimer's Disease
Ionis Pharmaceuticals, Inc. 46